K Boost Pilot Grant Program for Clinical and Translational Studies

Please note: the deadline for applications has been extended to April 24th, 2020

The Institute for Clinical and Translational Science is soliciting applications to qualified and promising scientists early in their faculty careers who have obtained K funding (e.g.: K08, K23, K25, K12, VA) from the NIH or other funding agencies in areas that reflect the mission of the ICTS to encourage translational science across the UI campus.

The goal of this program is to provide supplemental support for research costs or additional salary support for key personnel to NIH K awards that meet these criteria. The supplement will support research that emphasizes either basic or clinical areas relevant to ICTS mission. The award should focus on developing preliminary data that will allow the investigator to submit an independent NIH R award.


Funding of up to $25,000 during the current CTSA budget period may be requested.

Key dates

  • Full application due: April 24, 2020
  • Notice of award: June 1, 2020

Eligibility and project requirements

1. The principal investigator must be a full-time University of Iowa faculty member.

2. Team science - teams will be required to attend one Team Science Workshop at a later date.

3. Progress reports and citation requirements

Awardees will be expected to submit final progress report at the end of the funded period.

Awardees are expected to publish their findings in scholarly peer-reviewed journals and present their research at professional meetings and to cite the University of Iowa CTSA NIH award (number UL1TR002537) on each publication, press release, or other documents about research supported by this award.

Evaluation criteria

Each full proposal is scored by three independent reviewers. The review committee evaluates full proposals according to three equally weighted criteria for innovation, scientific merit, and potential for future funding.

Evaluation of pink sheets from any submitted grants and whether they mention specific issues that were deficient that could be easily corrected (e.g. needs to show that they can make a specific transgenic mouse, pilot data from specific parts of the proposal, etc) are also factored into the decision.

Budget guidelines

  • Funds for laboratory supplies, small equipment, patient costs, and consultants are allowable.
  • Funds may be requested for study-related personnel salaries.
  • Funds cannot be used to support faculty salary.
  • Travel expenses are not allowable.


No project involving human or live vertebrate animal subjects may be initiated without NCATS prior approval. A prior approval request must be submitted to NCATS no later than 30 days before the proposed implementation of any research involving human or live vertebrate animal subjects.

Applications that involve human or vertebrate animals must include proof of IRB or IACUC submission by the application deadline.

If it has been determined by the PI that this study does not require IRB approval, please submit a Human Subjects Research Determination form through HawkIRB. Attach the submitted determination form and the Human Subjects Office response to the application.

Deadline for submission: April 17th, 2020

PILOT Grant Application Requirements

  1. Summary statement for the current K Award
    1. The applicant must also submit a copy of the entire K award
  2. Abstracts/Relevance:
    1. Maximum of 250 words/2,000 characters, including spaces
    2. Provide a statement explaining the subject of the proposal and how it will allow the PI to submit an R01
    3. Include the date of expected submission
  3. Research goals:
    1. Maximum of one page
    2. Background and Preliminary Data
    3. Specific Aims
    4. How this work will help you submit a successful R01
  4. Current Curriculum Vitae
  5. Budget:
    1. Budget justification
    2. NIH Biographical Sketch

Submit application to Jamie Thrams (charles-thrams@uiowa.edu)

Contact information

Dr. Joseph Zabner

Jamie Thrams - administrative questions


Help the Institute for Clinical and Translational Science at the University of Iowa continue making new strides in medical research by citing the NIH CTSA program grant UL1TR002537.